This inventor holds 1 USPTO granted patent. Top assignee: Molecure S.a.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Gleb Andryianau: Innovator in Chitinase Inhibitors
Introduction
Gleb Andryianau is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as chitinase inhibitors. His work is aimed at addressing various health conditions, showcasing his commitment to innovation in healthcare.
Latest Patents
Gleb Andryianau holds a patent for "Substituted amino triazoles useful as chitinase inhibitors." This patent discloses amino triazole compounds that inhibit acidic mammalian chitinase and chitotriosidase. The compounds are designed to treat asthma reactions caused by allergens, as well as a range of other conditions including acute and chronic inflammatory diseases, autoimmune diseases, dental diseases, neurologic diseases, metabolic diseases, liver diseases, polycystic ovary syndrome, endometriosis, and cancer. He has 1 patent to his name.
Career Highlights
Gleb is currently employed at Molecure S.A., where he continues to advance his research and development efforts. His work at the company reflects his dedication to creating innovative solutions in the pharmaceutical industry.
Collaborations
Gleb collaborates with talented individuals such as Marzena Mazur and Lukasz Joachimiak. Their combined expertise contributes to the success of their projects and enhances the research environment at Molecure S.A.
Conclusion
Gleb Andryianau is a prominent figure in the field of medicinal chemistry, with a focus on developing chitinase inhibitors that have the potential to treat various diseases. His innovative work and collaborations highlight the importance of research in improving healthcare outcomes.